| Application no. and date | 14721905.9 (espacenet) (Federated) (European Patent Register), 20140508 | | Patent/reg. no. and date | DK/EP 2994125, 20180801 | | Publication date | 20160316 | | Priority no. and date | EP 13167358, 20130510 | | EP pub. no. and date |
EP 2994125 20160316 | | Effective date | | | Applicant/owner | Boehringer Ingelheim International GmbH, Binger Strasse 173
55216 Ingelheim am Rhein, DE | | Applicant ref. no. | 161829 | | Inventor | GASCHLER-MARKEFSKI, Birgit, Boehringer Ingelheim GmbH
Corporate Patents
Binger Strasse 173
55216 Ingelheim Am Rhein, DE,
KAISER, Rolf, Boehringer Ingelheim GmbH
Corporate Patents
Binger Strasse 173
55216Ingelheim Am Rhein, DE | | Representative | AWA Denmark A/S, Strandgade 56, 1401 København K, DK | | Opponent | | | IPC Class | A61K 31/337 (2006.01) , A61K 31/496 (2006.01) , A61K 31/519 (2006.01) , A61K 45/06 (2006.01) , A61P 35/00 (2006.01) | | Title | NINTEDANIB TIL ANVENDELSE I BEHANDLING AF NSCLC | | Int. application no. | EP2014059456 | | Int. publication no. | WO2014180955 | | Related patent (certificate) | | | Status | Ophævet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
